BOSTON (S&P Global Ratings) Feb. 1, 2019--S&P Global Ratings today withdrew its 'CCC-' issue-level rating and '6' recovery rating on Vyaire Medical Inc.'s second-lien debt at the issuer's request. All of our other ratings on Vyaire, including the 'CCC+' issuer credit rating and our 'CCC+' issue-level rating and '3' recovery rating on the company's first-lien credit facility, are unaffected by this announcement.
From London to San Francisco, to our home base in (Saint Helier) Jersey, we’re looking for extraordinary and creative scientists to help us drive the field forward.
AC Investment Inc. currently does not act as an equities executing broker or route orders containing equities securities. If AC Invest’s business model were to change and it begins routing non-directed orders in NMS securities, it will comply with the disclosure requirement of Rule 606.
77 Massachusetts Avenue Cambridge, MA 02139 617-253-1000 pr@ademcetinkaya.com